FACTS ABOUT NEW ADVANCEMENTS IN BRD4 INHIBITION THERAPY ABBV-744 REVEALED

In Section A, individuals will acquire distinctive doses and schedules of oral ABBV-744 pill to identify safe dosing routine. Added individuals will probably be enrolled at the discovered monotherapy dosign routine. In Phase B, participants will acquire oral ruxolitinib and ABBV-744 might be supplied as "incorporate-on" therapy. In Segment C, membe